Triazolyl-indolo-quinoxaline triggers differential cell death pathways in pancreatic cancer via ROS/p38 axis. - Yoon B; Suresh RN; Shivakumara CS; Harsha KB; Mohan CD; Sethi G; Rangappa KS; Ahn KS (Chemico-biological interactions, 2025)